Patents by Inventor Donald A. Harn, JR.

Donald A. Harn, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Listeria-based adjuvants
    Patent number: 10064898
    Abstract: This invention provides methods and compositions for using Listeria monocytogenes as an adjuvant for enhancing immune responses in a subject.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 4, 2018
    Assignees: ADVAXIS, INC., UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: John Rothman, Anu Wallecha, Reshma Singh, Donald A. Harn, Jr., Yvonne Paterson
  • Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
    Patent number: 9943590
    Abstract: This invention relates to methods of using a Listeria vaccine vector to induce a Th1 immune response in subjects having persistent Th2 immune response profiles.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: April 17, 2018
    Assignees: The Trustees of the University of Pennsylvania, University of Georgia Research Foundation, Inc.
    Inventors: Donald A. Harn, Jr., Yvonne Paterson, Lisa McEwen
  • LISTERIA-BASED ADJUVANTS
    Publication number: 20160324903
    Abstract: This invention provides methods and compositions for using Listeria monocytogenes as an adjuvant for enhancing immune responses in a subject.
    Type: Application
    Filed: July 27, 2016
    Publication date: November 10, 2016
    Applicants: ADVAXIS, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventors: John ROTHMAN, Anu WALLECHA, Reshma SINGH, Donald A. HARN, JR., Yvonne PATERSON
  • Listeria-based adjuvants
    Patent number: 9463227
    Abstract: This invention provides methods and compositions for using Listeria monocytogenes as an adjuvant for enhancing immune responses in a subject.
    Type: Grant
    Filed: March 12, 2012
    Date of Patent: October 11, 2016
    Assignees: ADVAXIS, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventors: John Rothman, Anu Wallecha, Reshma Singh, Donald A. Harn, Jr., Yvonne Paterson
  • USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE UNRESPONSIVENESS IN PARASITICALLY INFECTED INDIVIDUALS
    Publication number: 20160256538
    Abstract: This invention relates to methods of using a Listeria vaccine vector to induce a Th1 immune response in subjects having persistent Th2 immune response profiles.
    Type: Application
    Filed: October 7, 2015
    Publication date: September 8, 2016
    Inventors: Donald A. HARN, JR., Yvonne Paterson, Lisa McEwen
  • Use of vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
    Patent number: 9226958
    Abstract: This invention relates to methods of using a Listeria vaccine vector to induce a Th1 immune response in subjects having persistent Th2 immune response profiles.
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: January 5, 2016
    Assignees: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Donald A. Harn, Jr., Yvonne Paterson, Lisa McEwen
  • USE OF LISTERIA VACCINE VECTORS TO REVERSE VACCINE UNRESPONSIVENESS IN PARASITICALLY INFECTED INDIVIDUALS
    Publication number: 20130259891
    Abstract: This invention relates to methods of using a Listeria vaccine vector to induce a Th1 immune response in subjects having persistent Th2 immune response profiles.
    Type: Application
    Filed: October 3, 2011
    Publication date: October 3, 2013
    Inventors: Donald A. Harn, JR., Yvonne Paterson, Lisa Mcewen